Article Versions Notes

van Lieshout L, van de Stolpe A, van der Ploeg P, Bowtell D, de Hullu J, Piek J. Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel Approach to a Long-Standing Enigma. Cancers. 2020; 12(9):2660. https://doi.org/10.3390/cancers12092660

van Lieshout, Laura, Anja van de Stolpe, Phyllis van der Ploeg, David Bowtell, Joanne de Hullu, and Jurgen Piek. 2020. "Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel Approach to a Long-Standing Enigma" Cancers 12, no. 9: 2660. https://doi.org/10.3390/cancers12092660

van Lieshout, L., van de Stolpe, A., van der Ploeg, P., Bowtell, D., de Hullu, J., & Piek, J. (2020). Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel Approach to a Long-Standing Enigma. Cancers, 12(9), 2660. https://doi.org/10.3390/cancers12092660